Tasos Konidaris, Executive Vice President & CFO at Amneal Pharmaceuticals, Inc. (AMRX), sold 999,460 shares at $9.43 ($9.3M) on 2025-08-15, disclosed to the SEC on 2025-08-15.
Open-market sale of $9.3M AMRX by Executive Vice President & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.22 | 161,365 | $1.5M | 16.0% |
| 2 | $9.22 | 161,365 | $1.5M | 16.0% |
| 3 | $9.30 | 119,206 | $1.1M | 11.9% |
| 4 | $9.30 | 119,206 | $1.1M | 11.9% |
| 5 | $9.43 | 219,159 | $2.1M | 22.2% |
| 6 | $9.43 | 219,159 |
| $2.1M |
| 22.2% |
| Total | $9.33 avg | 999,460 | $9.3M | 100% |